MeSH term
Frequency | Condition_Probility | Adult | 2 | 0.0 |
Aged | 8 | 0.0 |
Base Sequence | 5 | 0.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Genotype | 7 | 0.0 |
Humans | 22 | 0.0 |
Logistic Models | 2 | 0.0 |
Male | 8 | 0.0 |
Middle Aged | 7 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Risk Factors | 3 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Animals | 7 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 3 | 0.0 |
Aged, 80 and over | 5 | 0.0 |
Alleles | 3 | 0.0 |
Cystatins/*genetics | 9 | 29.0 |
Female | 6 | 0.0 |
Odds Ratio | 2 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Alzheimer Disease/*genetics | 5 | 1.0 |
Case-Control Studies | 2 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Apolipoproteins E/genetics | 3 | 0.0 |
Age of Onset | 2 | 0.0 |
Genetic Predisposition to Disease | 4 | 0.0 |
Haplotypes | 2 | 0.0 |
Homozygote | 2 | 0.0 |
*Chromosomes, Human, Pair 20 | 5 | 4.0 |
Cloning, Molecular | 2 | 0.0 |
Mice | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Cerebral Amyloid Angiopathy/*genetics | 2 | 66.0 |
Blotting, Southern | 3 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
DNA Probes | 2 | 0.0 |
*Multigene Family | 2 | 0.0 |
*Cystatins | 2 | 66.0 |
Proteins/*genetics | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Blotting, Western | 2 | 0.0 |
Amyloid beta-Protein Precursor/genetics | 2 | 4.0 |
Membrane Proteins/genetics | 2 | 0.0 |
tau Proteins/genetics | 2 | 28.0 |
